In Vitro Toxicology Testing Market worth 8.74 Billion USD by 2022 - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

In Vitro Toxicology Testing Market worth 8.74 Billion USD by 2022

Description:

The In vitro toxicology testing market was valued at USD 5.99 Billion in 2016 and is expected to grow at a CAGR of 6.6% during the forecast period to reach to USD 8.74 Billion by 2022 – PowerPoint PPT presentation

Number of Views:7

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: In Vitro Toxicology Testing Market worth 8.74 Billion USD by 2022


1
In Vitro Toxicology Testing Market worth 8.74
Billion USD by 2022
www.MarketsandMarkets.com
2
According to a new market research report "In
Vitro Toxicology Testing Market by Products
(Assays) Services, Toxicity Endpoints Tests
(ADME, Skin, Genotoxicity, Organ Toxicity),
Technology (Cell-based, HTS), Method (Cellular
Assays, Ex-Vivo), Industry (Pharmaceutical,
Cosmetics) - Forecast to 2022", The in vitro
toxicology testing market is expected to reach
USD 8.74 Billion by 2022 from an estimated USD
6.34 Billion in 2017, at a CAGR of 6.6.
3
  • Browse 139 Market Data Tables and 32 Figures
    spread through 253 Pages and in-depth TOC on "In
    Vitro Toxicology Testing Market by Products
    (Assays) Services, Toxicity Endpoints Tests
    (ADME, Skin, Genotoxicity, Organ Toxicity),
    Technology (Cell-based, HTS), Method (Cellular
    Assays, Ex-Vivo), Industry (Pharmaceutical,
    Cosmetics) - Forecast to 2022"
  • https//www.marketsandmarkets.com/Market-Reports/i
    n-vitro-toxicology-testing-market-209577065.html
  • Early buyers will receive 10 customization on
    reports.
  • The key factors driving the growth of this market
    include opposition to animal testing, growing
    demand for in vitro technology in the European
    market, new and promising technologies, and
    increasing RD expenditure to detect toxicity at
    an early stage.
  • By Toxicity Endpoints and Tests, ADME hold the
    largest market share in 2017
  • Cell culture technology to hold the largest
    market share in 2017
  • US expected to hold the largest share of the in
    vitro toxicology testing market in 2017
  • The major players in the global in vitro
    toxicology testing market include Cyprotex (An
    Evotec AG subsidiary, Germany), Covance (A
    Laboratory Corporations of America Holdings
    subsidiary, US), Eurofins Scientific SE
    (Luxembourg), GE Healthcare (US), Thermo Fisher
    Scientific (US), SGS SA (Switzerland), Promega
    Corporation (US), Merck KGaA (Germany), Charles
    River Laboratories, Inc. (US), and Lonza Group
    Ltd. (Switzerland), among others.
About PowerShow.com